Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry.

Reidy KJ, Hjorten RC, Simpson CL, Rosenberg AZ, Rosenblum SD, Kovesdy CP, Tylavsky FA, Myrie J, Ruiz BL, Haque S, Mozhui K, Nelson GW, David VA, Yang X, Suzuki M, Jacob J, Reznik SE, Kaskel FJ, Kopp JB, Winkler CA, Davis RL.

Am J Hum Genet. 2018 Sep 6;103(3):367-376. doi: 10.1016/j.ajhg.2018.08.002. Epub 2018 Aug 30.

2.

Editorial: Nephrotic Syndrome in Pediatric Patients.

Woroniecki RP, Swiatecka-Urban A, Kaskel FJ.

Front Pediatr. 2017 Aug 3;5:167. doi: 10.3389/fped.2017.00167. eCollection 2017. No abstract available.

3.

Renal and Cardiovascular Morbidities Associated with APOL1 Status among African-American and Non-African-American Children with Focal Segmental Glomerulosclerosis.

Woroniecki RP, Ng DK, Limou S, Winkler CA, Reidy KJ, Mitsnefes M, Sampson MG, Wong CS, Warady BA, Furth SL, Kopp JB, Kaskel FJ.

Front Pediatr. 2016 Nov 17;4:122. eCollection 2016.

4.

Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates: Design of a Retrospective Cohort Study.

Jetton JG, Guillet R, Askenazi DJ, Dill L, Jacobs J, Kent AL, Selewski DT, Abitbol CL, Kaskel FJ, Mhanna MJ, Ambalavanan N, Charlton JR; Neonatal Kidney Collaborative.

Front Pediatr. 2016 Jul 19;4:68. doi: 10.3389/fped.2016.00068. eCollection 2016.

5.

APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.

Ng DK, Robertson CC, Woroniecki RP, Limou S, Gillies CE, Reidy KJ, Winkler CA, Hingorani S, Gibson KL, Hjorten R, Sethna CB, Kopp JB, Moxey-Mims M, Furth SL, Warady BA, Kretzler M, Sedor JR, Kaskel FJ, Sampson MG.

Nephrol Dial Transplant. 2017 Jun 1;32(6):983-990. doi: 10.1093/ndt/gfw061.

6.

Perceived appetite and clinical outcomes in children with chronic kidney disease.

Ayestaran FW, Schneider MF, Kaskel FJ, Srivaths PR, Seo-Mayer PW, Moxey-Mims M, Furth SL, Warady BA, Greenbaum LA.

Pediatr Nephrol. 2016 Jul;31(7):1121-7. doi: 10.1007/s00467-016-3321-9. Epub 2016 Feb 8.

7.

Complete Remission in the Nephrotic Syndrome Study Network.

Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10.

8.

Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.

Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, Furth SL, Warady BA, Portale AA, Melamed ML.

Pediatr Nephrol. 2016 Jan;31(1):121-9. doi: 10.1007/s00467-015-3190-7. Epub 2015 Aug 26.

9.

Validation of automated Greulich-Pyle bone age determination in children with chronic renal failure?

Ranabothu S, Kaskel FJ.

Pediatr Nephrol. 2015 Jul;30(7):1051-2. doi: 10.1007/s00467-015-3103-9. Epub 2015 Apr 11.

PMID:
25862023
10.

Sponsors meet scientists to speed pediatric medicines development.

Davis JM, Smoyer WE, Connor EM, Huskins WC, Pastern C, Purucker M, Schrader EC, Jackson CR, Kaskel FJ, Hirschfeld S.

Sci Transl Med. 2015 Mar 18;7(279):279fs11. doi: 10.1126/scitranslmed.aaa2045.

11.

Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.

Kopp JB, Winkler CA, Zhao X, Radeva MK, Gassman JJ, D'Agati VD, Nast CC, Wei C, Reiser J, Guay-Woodford LM, Pollak MR, Hildebrandt F, Moxey-Mims M, Gipson DS, Trachtman H, Friedman AL, Kaskel FJ; FSGS-CT Study Consortium.

J Am Soc Nephrol. 2015 Jun;26(6):1443-8. doi: 10.1681/ASN.2013111242. Epub 2015 Jan 8.

12.

Medication adherence and growth in children with CKD.

Akchurin OM, Schneider MF, Mulqueen L, Brooks ER, Langman CB, Greenbaum LA, Furth SL, Moxey-Mims M, Warady BA, Kaskel FJ, Skversky AL.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1519-25. doi: 10.2215/CJN.01150114. Epub 2014 Jun 26.

13.

Medication adherence in the transition of adolescent kidney transplant recipients to the adult care.

Akchurin OM, Melamed ML, Hashim BL, Kaskel FJ, Del Rio M.

Pediatr Transplant. 2014 Aug;18(5):538-48. doi: 10.1111/petr.12289. Epub 2014 May 13.

14.

The CTSA mentored career development program: supporting the careers of child health investigators.

Byington CL, Higgins S, Kaskel FJ, Purucker M, Davis JM, Smoyer WE.

Clin Transl Sci. 2014 Feb;7(1):44-7. doi: 10.1111/cts.12122. Epub 2013 Nov 8.

15.

Late steroid resistance in childhood nephrotic syndrome: do we now know more than 40 years ago?

Akchurin OM, Kaskel FJ.

Pediatr Nephrol. 2013 Aug;28(8):1157-60. doi: 10.1007/s00467-013-2509-5. Epub 2013 May 25.

PMID:
23708761
16.

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.

Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M.

Kidney Int. 2013 Apr;83(4):749-56. doi: 10.1038/ki.2012.428. Epub 2013 Jan 16.

17.

Association of histologic variants in FSGS clinical trial with presenting features and outcomes.

D'Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, Cohen AH, Gipson DS, Gassman JJ, Radeva MK, Moxey-Mims MM, Friedman AL, Kaskel FJ, Trachtman H, Alpers CE, Fogo AB, Greene TH, Nast CC.

Clin J Am Soc Nephrol. 2013 Mar;8(3):399-406. doi: 10.2215/CJN.06100612. Epub 2012 Dec 6.

18.

Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.

Hogg RJ, Friedman A, Greene T, Radeva M, Budisavljevic MN, Gassman J, Gipson DS, Jefferson JA, John EG, Kaskel FJ, Moudgil A, Moxey-Mims M, Ortiz LA, Schelling JR, Schnaper W, Srivastava T, Trachtman H, Vehaskari VM, Wong C, Woronieki RP, Van Why SK, Zolotnitskaya A.

Clin J Am Soc Nephrol. 2013 Feb;8(2):211-8. doi: 10.2215/CJN.08330812. Epub 2012 Nov 8.

19.

Focal segmental glomerulosclerosis.

D'Agati VD, Kaskel FJ, Falk RJ.

N Engl J Med. 2011 Dec 22;365(25):2398-411. doi: 10.1056/NEJMra1106556. Review. No abstract available.

PMID:
22187987
20.

Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006.

Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML.

J Clin Endocrinol Metab. 2011 Dec;96(12):3838-45. doi: 10.1210/jc.2011-1600. Epub 2011 Sep 28.

21.

Clinical trial of focal segmental glomerulosclerosis in children and young adults.

Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D'Agati VD, Friedman AL.

Kidney Int. 2011 Oct;80(8):868-78. doi: 10.1038/ki.2011.195. Epub 2011 Jul 6.

22.

HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort.

Thomas R, Sanna-Cherchi S, Warady BA, Furth SL, Kaskel FJ, Gharavi AG.

Pediatr Nephrol. 2011 Jun;26(6):897-903. doi: 10.1007/s00467-011-1826-9. Epub 2011 Mar 5.

23.

Chronic kidney disease stages are appropriate at all ages.

Goilav B, Kaskel FJ.

Blood Purif. 2011;31(1-3):125-9. doi: 10.1159/000321850. Epub 2011 Jan 10. Review.

24.

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.

Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, Greene TH, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Middleton JP, Vehaskari VM, Hogan SL, Vento S, Flynn PA, Powell LM, McMahan JL, Siegel N, Friedman AL.

Kidney Int. 2011 Mar;79(6):678-685. doi: 10.1038/ki.2010.485. Epub 2010 Dec 22.

25.

The association between abnormal birth history and growth in children with CKD.

Greenbaum LA, Muñoz A, Schneider MF, Kaskel FJ, Askenazi DJ, Jenkins R, Hotchkiss H, Moxey-Mims M, Furth SL, Warady BA.

Clin J Am Soc Nephrol. 2011 Jan;6(1):14-21. doi: 10.2215/CJN.08481109. Epub 2010 Oct 28.

26.

8th International Symposium on Growth and Nutrition in Children with Chronic Renal Disease: 28-30 May 2009, Oviedo, Asturias, Spain.

Santos F, Kaskel FJ, Mak RH, Caldas A.

Pediatr Nephrol. 2010 Apr;25(4):581-2. doi: 10.1007/s00467-009-1401-9. No abstract available.

27.

Pediatrics: Timely diagnosis of primary hyperoxaluria type 1.

Chand AQ, Kaskel FJ.

Nat Rev Nephrol. 2009 Dec;5(12):670-1. doi: 10.1038/nrneph.2009.186. No abstract available.

PMID:
19935811
28.

Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004.

Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML.

Pediatrics. 2009 Sep;124(3):e362-70. doi: 10.1542/peds.2009-0051. Epub 2009 Aug 3.

29.

It's not over till the last glomerulus forms.

Thomas R, Kaskel FJ.

Kidney Int. 2009 Aug;76(4):361-3. doi: 10.1038/ki.2009.181. Review.

30.

Pediatric nephrotic syndrome: from the simple to the complex.

Lane JC, Kaskel FJ.

Semin Nephrol. 2009 Jul;29(4):389-98. doi: 10.1016/j.semnephrol.2009.03.015. Review.

PMID:
19615560
31.

Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidism.

Kumar J, Gordillo R, Kaskel FJ, Druschel CM, Woroniecki RP.

J Pediatr. 2009 Feb;154(2):263-6. doi: 10.1016/j.jpeds.2008.08.023. Epub 2008 Sep 27.

32.

Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts.

Bamgbola OF, Kaskel FJ, Coco M.

Pediatr Nephrol. 2009 Mar;24(3):571-9. doi: 10.1007/s00467-008-0954-3. Epub 2008 Sep 18.

PMID:
18800231
33.

Validation of a composite scoring scheme in the diagnosis of folate deficiency in a pediatric and adolescent dialysis cohort.

Kaskel FJ, Bamgbola OF.

J Ren Nutr. 2008 Sep;18(5):430-9. doi: 10.1053/j.jrn.2008.05.009.

PMID:
18721738
34.

Parent perspectives of health related quality of life in adolescents with chronic kidney disease due to underlying urological disorders: an assessment using the Child Health Questionnaire-Parent Form 50.

Dodson JL, Gerson AC, Hsiao CJ, Kaskel FJ, Weiss RA, Furth SL.

J Urol. 2008 Oct;180(4 Suppl):1700-4; discussion 1704. doi: 10.1016/j.juro.2008.03.117. Epub 2008 Aug 20.

PMID:
18718618
35.

Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.

Woroniecki RP, Shatat IF, Supe K, Du Z, Kaskel FJ.

Am J Nephrol. 2008;28(1):83-90. Epub 2007 Oct 3. Erratum in: Am J Nephrol. 2008;28(1):179.

PMID:
17914249
36.
37.

Pathophysiology of focal segmental glomerulosclerosis.

Reidy K, Kaskel FJ.

Pediatr Nephrol. 2007 Mar;22(3):350-4. Epub 2007 Jan 10. Review.

38.

The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.

Chalmers L, Kaskel FJ, Bamgbola O.

Adv Chronic Kidney Dis. 2006 Oct;13(4):352-64. Review.

PMID:
17045221
39.

Safety and efficacy of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.

Kaskel FJ.

Nat Clin Pract Nephrol. 2006 May;2(5):244-5. No abstract available.

PMID:
16932433
40.

Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood.

Woroniecki RP, Orlova TN, Mendelev N, Shatat IF, Hailpern SM, Kaskel FJ, Goligorsky MS, O'Riordan E.

Am J Nephrol. 2006;26(3):258-67. Epub 2006 Jun 7.

PMID:
16763371
41.

Glomerular expression of transforming growth factor-beta (TGF-beta) isoforms in mice lacking CD2-associated protein.

Woroniecki RP, Schiffer M, Shaw AS, Kaskel FJ, Bottinger EP.

Pediatr Nephrol. 2006 Mar;21(3):333-8. Epub 2005 Dec 31.

PMID:
16388393
42.

The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Belay B, Esteban-Cruciani N, Walsh CA, Kaskel FJ.

Pediatr Nephrol. 2006 Mar;21(3):308-17. Epub 2005 Dec 23. Review.

PMID:
16374652
43.

Report of an NIH task force on research priorities in chronic kidney disease in children.

Chesney RW, Brewer E, Moxey-Mims M, Watkins S, Furth SL, Harmon WE, Fine RN, Portman RJ, Warady BA, Salusky IB, Langman CB, Gipson D, Scheidt P, Feldman H, Kaskel FJ, Siegel NJ.

Pediatr Nephrol. 2006 Jan;21(1):14-25. Epub 2005 Oct 27. No abstract available.

PMID:
16252095
44.

Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance.

Bamgbola OF, del Rio M, Kaskel FJ, Flynn JT.

Pediatr Nephrol. 2005 Jul;20(7):989-93. Epub 2005 Apr 21.

PMID:
15843999
45.

Induction of renal tubular cell apoptosis in focal segmental glomerulosclerosis: roles of proteinuria and Fas-dependent pathways.

Erkan E, Garcia CD, Patterson LT, Mishra J, Mitsnefes MM, Kaskel FJ, Devarajan P.

J Am Soc Nephrol. 2005 Feb;16(2):398-407. Epub 2004 Dec 15. Erratum in: J Am Soc Nephrol. 2005 Apr;16(4):1150.

46.

Uremic malnutrition-inflammation syndrome in chronic renal disease: a pathobiologic entity.

Bamgbola FO, Kaskel FJ.

J Ren Nutr. 2003 Oct;13(4):250-8. Review. No abstract available.

PMID:
14566761
47.

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial.

Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DW, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH; Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial.

JAMA. 2003 Sep 10;290(10):1337-44.

PMID:
12966125
48.

Non-cardiogenic pulmonary edema during basiliximab induction in three adolescent renal transplant patients.

Bamgbola FO, Del Rio M, Kaskel FJ, Flynn JT.

Pediatr Transplant. 2003 Aug;7(4):315-20.

PMID:
12890011
49.

Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury.

Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, Tellis V, Devarajan P.

Transplantation. 2003 Jul 15;76(1):50-4.

PMID:
12865785
50.

Differential gene expression following early renal ischemia/reperfusion.

Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P.

Kidney Int. 2003 May;63(5):1714-24.

Supplemental Content

Loading ...
Support Center